Harvard Bioscience 4th Quarter 2023 Financial Results

 

• Q4Revenuesof$28.2 million
• Q4GrossMarginof58.0% (230 bps year-over-year improvement)
• Q4operatingincome of$0.3 million,adjustedoperatingincome of $3.3 million
• Strongoperatingcashflowenabled 2023 debtreduction of$10.5 million and a significant decrease in net leverage

https://www.biospace.com/article/releases/harvard-bioscience-announces-fourth-quarter-2023-financial-results/